Diploma in pharmacy from recognized institute. should have registered under Jharkhand state pharmacy council
Computer proficiency (MS Office) & internet
Post-graduate degree in Life Sciences, Biotechnology, Biochemistry, Microbiology, Toxicology, Molecular oncology, Bioinformatics, Genetics with two years of research experience in Biochemistry, Biotechnology, Immunology, Molecular Biology.
The candidate must have a first class Post-Graduate Degree in any branch of Life Sciences. Candidates with atleast one year experience in cell culture and molecular biology techniques.
Understanding of drug development processes and proficiency in quality principles driving drug development such as GMP and applicable regulations and policies.
Sound knowledge of analytical method development and Method validation using HPLC as per guidelines. Knowledge of calibration and operations of all equipment like balance, ph meter, in analytical operation.
Responsible for reviewing batch manufacturing, monitoring process steps, and reviewing documentation. Additionally, support in handling deviations, change control, and CAPA management, internal and external audits to maintain compliance.
Preparation and review of Protocol as per sponsor and various regulatory requirements. Preparation and review of Informed Consent Document in English and vernacular language according to protocol.
Developing India-specific Artwork, Support to Regulatory dossier preparation and submissions like New drug applications, Site registration, Clinical trials and Import licence. Managing Registration samples right from dispatch of samples till the report.
As a Senior Auditor Quality Assurance at ICON, you will play a pivotal role in ensuring the quality and compliance of clinical trials, interpreting regulatory requirements, and contributing to the advancement of in Native treatments and therapies.
NVIDIA announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s agreement with DCAI to use the Gefion sovereign AI supercomputer.
Pharmazz, Inc. a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has announced a 25 million USD equity investment from Sun Pharmaceutical Industries Limited
Telix Pharmaceuticals Limited announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix (kit for the preparation of gallium-68 , is now commercially available nationally in the United States (U.S.).